Reimbursed with a limitationOriginator productATC R03AL12

Enerzair Breezhaler Inha

Enerzair Breezhaler Inha is an originator product from Novartis Pharma Schweiz AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 75.80 to CHF 194.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Novartis Pharma Schweiz AG
ATC code
R03AL12
IT group
03.04.50 Andere Antiasthmatica
Active substances
Indacaterolum, Glycopyrronium, Mometasoni-17 furoas
Preparation type
Originator product
On the SL since
01/01/2021
Last price change
01/12/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Enerzair Breezhaler Inha Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inh Kaps 150/50/160mcgBlist 30 StkCHF 54.58CHF 75.8001/01/2021B7680675960040
Inh Kaps 150/50/160mcgBlist 90 StkCHF 163.74CHF 194.5001/01/2021B7680675960057

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/01/2021

Zur Erhaltungstherapie von Patienten mit schwerem Asthma, welche mit einer Erhaltungstherapie aus einem lang wirksamen Beta2-Agonisten und einem hochdosierten inhalativen Kortikosteroid nicht ausreichend eingestellt sind und eine oder mehr Exazerbationen in den letzten 12 Monaten erlitten haben
oder
für Patienten mit schwerem Asthma, welche bereits mit einer Kombination von LABA/LAMA und ICS mit mehreren Inhalatoren therapiert werden.

FAQ

Is Enerzair Breezhaler Inha covered by Swiss health insurance?

Yes, but only under conditions. Enerzair Breezhaler Inha is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Enerzair Breezhaler Inha cost in Switzerland?

The public price is the maximum price set by the FOPH and for Enerzair Breezhaler Inha ranges from CHF 75.80 to CHF 194.50 per pack. The ex-factory price ranges from CHF 54.58 to CHF 163.74. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com